Thrombosis |
From Equipe INSERM E9907 and Unité INSERM U460 (P.R., M.P., J.-B.M.), Faculté Xavier Bichat, Paris, France.
Correspondence to Dr Marie-Christine Bouton, Faculté X. Bichat, Equipe INSERM E9907, BP 416, 75870 Paris, Cedex 18, France. E-mail mcbouton{at}bichat.inserm.fr
Objective Protease-nexin 1 (PN-1) belongs to the serpin superfamily and behaves as a specific thrombin inhibitor in the pericellular environment. Little is known about PN-1 expression and its regulation in the vascular system. In this study, we examined the expression of functionally active PN-1 in vitro in rat aortic smooth muscle cells and in vivo in rat arterial media and its regulation in hypertensive rats.
Methods and Results The vascular PN-1 formed specific covalent complexes with thrombin involving the catalytic site of the protease, and heparin increased the formation of these complexes. We also demonstrated PN-1 in rat arterial media by immunohistochemical staining. Moreover, we examined in vivo vascular expression of PN-1 in a model of chronic hypertension induced by long-term administration of NG-nitro-L-arginine methyl ester (L-NAME). Marked increases in PN-1 mRNA (3-fold) and protein (2-fold) were observed after 2 months of hypertension. Increased expression of PN-1 in the vascular wall was associated with an increase in the formation of complexes between radiolabeled-thrombin and PN-1, indicating that PN-1 was functional.
Conclusions PN-1 may thus participate in the mechanisms that regulate thrombin activity in the vessel wall.
Key Words: protease-nexin 1 smooth muscle cells aorta hypertension thrombin
This article has been cited by other articles:
![]() |
B. Fayard, F. Bianchi, J. Dey, E. Moreno, S. Djaffer, N. E. Hynes, and D. Monard The Serine Protease Inhibitor Protease Nexin-1 Controls Mammary Cancer Metastasis through LRP-1-Mediated MMP-9 Expression Cancer Res., July 15, 2009; 69(14): 5690 - 5698. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mansilla, Y. Boulaftali, L. Venisse, V. Arocas, O. Meilhac, J.-B. Michel, M. Jandrot-Perrus, and M.-C. Bouton Macrophages and Platelets Are the Major Source of Protease Nexin-1 in Human Atherosclerotic Plaque Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1844 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Bouton, L. Venisse, B. Richard, C. Pouzet, V. Arocas, and M. Jandrot-Perrus Protease Nexin-1 Interacts With Thrombomodulin and Modulates Its Anticoagulant Effect Circ. Res., April 27, 2007; 100(8): 1174 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fan, T. D. Wu, W. Li, and D. Kirchhofer Identification of Hepatocyte Growth Factor Activator Inhibitor-1B as a Potential Physiological Inhibitor of Prostasin J. Biol. Chem., October 14, 2005; 280(41): 34513 - 34520. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rossignol, B. Ho-Tin-Noe, R. Vranckx, M.-C. Bouton, O. Meilhac, H. R. Lijnen, M.-C. Guillin, J.-B. Michel, and E. Angles-Cano Protease Nexin-1 Inhibits Plasminogen Activation-induced Apoptosis of Adherent Cells J. Biol. Chem., March 12, 2004; 279(11): 10346 - 10356. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Kanse, T. Chavakis, N. Al-Fakhri, K. Hersemeyer, D. Monard, and K. T. Preissner Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1 J. Cell Sci., January 22, 2004; 117(3): 477 - 485. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |